Related Experiment Video

Updated: May 24, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

[Malignant pleural mesothelioma]

T Ploenes1, T Osei-Agyemang, U Nestle

  • 1Abt. Thoraxchirurgie der Albert-Ludwigs Universität Freiburg.

Deutsche Medizinische Wochenschrift (1946)
|March 1, 2012
PubMed

Insights

Malignant pleural mesothelioma (MPM) is an aggressive cancer linked to asbestos. Despite diagnostic advances, optimal treatment for this asbestos-related cancer remains debated, with peak incidence expected soon.

Area of Science:

  • Oncology
  • Environmental Medicine
  • Pathology

Context:

  • Malignant pleural mesothelioma (MPM) is a rare but aggressive cancer.
  • Asbestos exposure is the primary cause of MPM.
  • Europe anticipates a peak in MPM incidence within two decades due to past asbestos use.

Purpose:

  • To review the current diagnostic approaches for malignant pleural mesothelioma.
  • To discuss the existing treatment strategies for malignant pleural mesothelioma.
  • To provide an overview of the challenges in managing this asbestos-induced cancer.

Summary:

  • MPM is a highly aggressive tumor originating in the pleura, strongly associated with asbestos exposure.
  • The prognosis for MPM is poor, with a median survival of 7-9 months.
  • Optimal treatment strategies for MPM are still under investigation despite diagnostic progress.

Impact:

  • Highlights the ongoing challenge of managing asbestos-related diseases.
  • Underscores the need for improved diagnostic and therapeutic interventions for MPM.
  • Informs clinicians and researchers about the current landscape of MPM management.

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pleura of the Lungs01:13

Pleura of the Lungs

The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: